Download
Download by
Scanning QR Code
  • Download app

    Download app

  • Online Inquiry

    Log in to access Online Inquiry
+
Congratulations
You've successfully got advanced quotes worth 5000 HKD
Download APP >>
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Futubull > Quotes > 02179 RECBIO-B > Detailed Quotes

02179 RECBIO-B

Watchlist
22.300
-0.050-0.22%
Closed 06/30 16:08 CCT
High
22.650
Open
22.000
Turnover
1.79M
Low
22.000
Pre Close
22.350
Volume
80.00K
Market Cap
10.77B
P/E(TTM)
Loss
52wk High
28.300
Shares
482.96M
P/E(Static)
Loss
52wk Low
20.450
Float Cap
2.09B
Bid/Ask %
-34.78%
Historical High
28.300
Shs Float
93.64M
Volume Ratio
0.58
Historical Low
20.450
Dividend TTM
--
Div Yield TTM
--
P/B
5.26
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.08%
Amplitude
2.91%
Avg Price
22.336
Lot Size
500
Float Cap
2.09B
Bid/Ask %
-34.78%
Historical High
28.300
Shs Float
93.64M
Volume Ratio
0.58
Historical Low
20.450
Dividend TTM
--
P/B
5.26
Dividend LFY
--
Turnover Ratio
0.08%
Amplitude
2.91%
Avg Price
22.336
Lot Size
500
Price Forecast

No Data

News

Comment

Company Overview More
Jiangsu Ruike Biotechnology Co., Ltd. is a Chinese company engaged in vaccine research and development. The company has a range of clinical and preclinical vaccines. The human papillomavirus (HPV) vaccine pipeline includes recombinant HPV9 candidate vaccine REC603, recombinant HPV bivalent candidate vaccine REC601 and REC602, recombinant HPV tetravalent vaccine REC604a and recombinant HPV9 vaccine REC604b. The company is also involved in the research and development of novel coronavirus vaccine. The company mainly sells its products in the domestic market.
CEO: Yong Liu
Market: Hong Kong motherboard
Futu Hot List
HKUSCN
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist
Back to the Top